PCSA — Processa Pharmaceuticals, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-10-02.
Performance
Technicals
Others in Healthcare
Measured signals that fired on PCSA
| date | signal | measured base rate |
|---|---|---|
| 2026-04-01 | Cluster buy: three or more insiders insider | +0.63% over 21 days · t = 1.84 · n = 3,050 not distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-08 | Ng George K Chief Executive Officer | Option exercise | 1.6K | — | — |
| 2026-07-01 | Ng George K Chief Executive Officer | Open-market purchase | 3.1K | 1.93 | 5.9K |
| 2026-06-30 | SKIBSTED RUSSELL Chief Financial Officer | Open-market purchase | 3.3K | 1.93 | 6.3K |
| 2026-06-30 | Young David Pres. Research & Development | Open-market purchase | 2.5K | 1.93 | 4.9K |
| 2026-06-30 | Guy Wendy Chief Administrative Officer | Open-market purchase | 2.4K | 1.93 | 4.7K |
| 2026-06-30 | Lin Patrick Chief Business - Strategy Off | Open-market purchase | 2.1K | 1.93 | 4.1K |
| 2026-06-26 | Yorke Justin W Director | Option exercise | 203 | — | — |
| 2026-06-26 | Pannu Geraldine Director | Option exercise | 203 | — | — |
| 2026-06-26 | Neal James R Director | Option exercise | 203 | — | — |
| 2026-06-26 | Baluch Khoso Director | Option exercise | 203 | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Connective Capital Management, LLC | 178.6K | 70.7K |
| Stonepine Capital Management, LLC | 138.9K | 55.0K |
| GEODE CAPITAL MANAGEMENT, LLC | 62.8K | 24.9K |
| VANGUARD CAPITAL MANAGEMENT LLC | 32.1K | 12.7K |
| VANGUARD FIDUCIARY TRUST CO | 27.4K | 10.9K |
| UBS Group AG | 6.4K | 2.5K |
| Tower Research Capital LLC (TRC) | 2.3K | 918 |
| CITIGROUP INC | 35 | 14 |
| JONES FINANCIAL COMPANIES LLLP | 17 | 7 |
| WELLS FARGO & COMPANY/MN | 15 | 6 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 4 | 2026-08-11 | 2026-08-08 | on EDGAR ↗ |
| 8-K | 2026-08-04 | 2026-07-30 | on EDGAR ↗ |
| 4 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
| 3 | 2026-07-30 | 2026-07-28 | on EDGAR ↗ |
| 8-K | 2026-07-29 | 2026-07-23 | on EDGAR ↗ |
| 4 | 2026-07-28 | 2026-07-26 | on EDGAR ↗ |
| 4 | 2026-07-28 | 2026-07-26 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Processa Pharmaceuticals, Inc. (PCSA) filed form 10-Q · 2026-08-14 · SEC EDGAR
Ask the AI about PCSA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →